Answer
Women of childbearing potential should use highly effective contraception while receiving TEPEZZA (teprotumumab) and for 6 months after its last administration.
Sources for this answer
- TEPEZZA 500 mg powder for concentrate for solution for infusionAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked